top of page

Working groups

Four working groups with motivated people collaborating worldwide.


Clinical cohort of patients

38 members

  • Create an infrastructure for multi-center trials ensuring compliance and high quality standards in terms of data collection and biobanking.

  • Harmonize available databases: study population and relevant variables.

  • Elaboration of guidelines document.


Development & evaluation of novel diagnostic methods

81 members

  • Focus on biomarkers based on host-pathogen interaction, technological platforms (imaging, artificial intelligence) and M/XDR molecular tests.

  • Describe the state of the art, advantages and pitfalls of diagnostic methods for TB and LTBI à current and future perspectives.


Designing novel TB therapeutical strategies

59 members

  • New drugs (repurposed/novel compounds) and host-directed therapies - preclinical testing, new approaches for clinical evaluation, methods for treatment monitoring and industry liaison.

  • Database of compounds/ drugs - protocols for testing efficacy in vitro and in vivo.

  • Describe and define treatment options and monitoring strategies - current and future perspectives.


Dissemination & communication

34 members

  • Science communication plan.

  • Dissemination activities.

  • Website and social media accounts.

  • Engage new researchers, other reference networks and private partners.

  • Coordinate and publish the WG’s results.

Interaction and impact

Would you like to join us?

  1. Read the Project Description Memorandum of Understanding.

  2. Inform the Chair of ADVANCE-TB, Alicia Lacoma, by email.

  3. Apply to join your Working Group(s) of interest.

Thanks for your interest in our Action!
We will get back to you as soon as possible.

bottom of page